Lucid raises Perspective Therapeutics stock target to $20
Capital Markets increased its price target on Perspective Therapeutics Inc (NYSE:CATX) shares to $20.00, up from the previous $15.00, while maintaining a Buy rating on the stock. The $259.2 million ...
Wedbush Reaffirms Outperform Rating for Perspective Therapeutics (NYSE:CATX)
Wedbush reissued their outperform rating on shares of Perspective Therapeutics (NYSE:CATX – Free Report) in a report released ...
Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...
Perspective Therapeutics (CATX) Receives a Buy from Truist Financial
In a report released today, Nicole Germino from Truist Financial maintained a Buy rating on Perspective Therapeutics (CATX – Research Report).
Promising Clinical Developments and Strong Financial Position Reinforce ‘Buy’ Rating for Perspective Therapeutics
Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Perspective Therapeutics (CATX – Research Report). The associated ...
The Bakersfield Californian10d
Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO ...
SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers through ...
Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science
Large pill size, high pill burden and palatability were identified as key barriers for phosphate binder adherenceLOS ALTOS, ...
Yahoo Finance7d
Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
On Friday, Perspective Therapeutics, Inc. (NYSE:CATX) revealed updated interim results from its ongoing Phase 1/2a trial of [212Pb]VMT-α-NET. The data will be presented at the 2025 American ...